Science Explorer Back to mapMap
Discussion
Researcher · Korea National University of Transportation · South Korea

Jeong Man An

Jeong Man An publishes mostly in Biomedical Engineering, Surgery and Molecular Biology, on topics such as Nanoplatforms for cancer theranostics, Graphene and Nanomaterials Applications and Wound Healing and Treatments.

ORCID 0000-0001-6164-2566 OpenAlex
World rank
#1,501,841
of 7,710,434 ranked researchers
Rank in South Korea
#16,977
of 162,609
Works
27
Citations
448
Citations per work
16.6
h-index
13
i10-index 13Top 45% in Biomedical Engineering
Jeong Man An

What does Jeong Man An research?

Jeong Man An's work is mostly in Engineering (26%), Medicine (15%), Biochemistry, Genetics and Molecular Biology (9%).

Everything else: 11 works · 39.6% of their workPhysical Sciences: 9 works · 32.1% of their workEngineering: 7 works · 25.9% of their workBiomedical Engineering: 7 works · 25.9% of their workMaterials Science: 2 works · 6.2% of their workBiomaterials: 2 works · 6.2% of their workHealth Sciences: 4 works · 14.8% of their workMedicine: 4 works · 14.8% of their workSurgery: 3 works · 9.9% of their workRehabilitation: 1 works · 4.9% of their workLife Sciences: 4 works · 13.5% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 8.6% of their workMolecular Biology: 2 works · 8.6% of their workImmunology and Microbiology: 1 works · 4.9% of their workImmunology: 1 works · 4.9% of their workTHEIR WORKJeong Man An27works
Life Sciences13%Physical Sciences32%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1139.6%
    1. Engineering725.9%
    2. Materials Science26.2%
    1. Medicine414.8%
    1. Biochemistry, Genetics and Molecular Biology28.6%
    2. Immunology and Microbiology14.9%
  1. 1Biomedical Engineering26% of their works
  2. 2Surgery10% of their works
  3. 3Molecular Biology9% of their works
  4. 4Biomaterials6% of their works
  5. 5Immunology5% of their works
  6. 6Rehabilitation5% of their works

Research topics

Which keywords describe Jeong Man An's research?

The keywords of their largest research topics: Nanoparticles, Drug Delivery, Biomedical Applications, Cancer Therapy, Tumor Targeting, Graphene, Nanomaterials and Photothermal Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Nanoparticles154 topics
  2. Drug Delivery133 topics
  3. Biomedical Applications102 topics
  4. Cancer Therapy102 topics
  5. Tumor Targeting102 topics
  6. Graphene71 topic
  7. Nanomaterials71 topic
  8. Photothermal Therapy71 topic
  9. Reactive Oxygen Species71 topic
  10. Regeneration41 topic
  11. Wound Healing41 topic
  12. Chitosan31 topic
  13. Mucosal31 topic
  14. Nanocarriers31 topic
  15. Pancreatic Islets31 topic
  16. Surface Engineering31 topic
  17. ß-Cell Dysfunction31 topic
  18. DNA nanotechnology21 topic
  19. RNA Interference21 topic
  20. Self-Assembly21 topic
  21. siRNA Delivery21 topic

Where does Jeong Man An work?

Jeong Man An's main affiliation in the publication record is Korea National University of Transportation, South Korea.

How many publications and citations does Jeong Man An have?

OpenAlex counts 27 works and 448 citations for Jeong Man An, an h-index of 13, ranking #1,501,841 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jeong Man An. Posts are plain text and can be reported.